Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Sep 16, 2021; 13(9): 391-406
Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.391
Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.391
Table 5 The results of multivariate analysis showing the predictors of gastrointestinal hemorrhage in a population of patients with gastrointestinal cancer
Predictors of GI hemorrhage | ||||
aOR | 95%CI | P value | ||
Demographic factors | ||||
Age (yr) | 1.01 | (1.01-1.02) | < 0.001 | |
Female | 0.84 | (0.81-0.86) | < 0.001 | |
Race | White- Reference | 1.00 | - | - |
Black | 1.27 | (1.22-1.31) | < 0.001 | |
Hispanic | 1.19 | (1.14-1.24) | < 0.001 | |
Asian or Pacific Islander | 1.42 | (1.34-1.50) | < 0.001 | |
Native American | 1.24 | (1.06-1.46) | 0.007 | |
Other | 1.13 | (1.05-1.21) | 0.001 | |
Socioeconomic factors | ||||
Insurance | Medicare- Reference | 1.00 | - | - |
Medicaid | 1.17 | (1.12-1.22) | < 0.001 | |
Private | 0.91 | (0.88-0.94) | < 0.001 | |
Self-pay | 1.44 | (1.34-1.56) | < 0.001 | |
No charge | 1.21 | (0.94-1.56) | 0.148 | |
Other | 1.03 | (0.95-1.12) | 0.468 | |
Median household income for patient ZIP Code | 1st quartile- Reference | 1.00 | - | - |
2nd quartile | 0.98 | (0.95-1.01) | 0.246 | |
3rd quartile | 0.96 | (0.93-0.99) | 0.022 | |
4th quartile | 0.94 | (0.90-0.97) | < 0.001 | |
Comorbidities | ||||
Acute kidney injury | 1.17 | (1.13-1.20) | < 0.001 | |
Chronic kidney disease | 1.22 | (1.18-1.26) | < 0.001 | |
Heart failure | 1.19 | (1.12-1.27) | < 0.001 | |
Cirrhosis and liver failure | 1.84 | (1.78-1.90) | < 0.001 | |
Cancer related | ||||
Metastasis | 0.93 | (0.90-0.95) | < 0.001 | |
Chemo and Immunotherapy | 0.74 | (0.72-0.77) | < 0.001 | |
Radiation gastroenteritis/proctitis | 2.39 | (2.02-2.81) | < 0.001 | |
Palliative care | 1.21 | (1.17-1.26) | < 0.001 | |
Nutritional status | ||||
Severe malnutrition and cachexia | 1.12 | (1.08-1.15) | < 0.001 | |
Obesity | 0.94 | (0.90-0.98) | 0.001 | |
Use of antithrombotic/anticoagulants | ||||
Aspirin/antiplatelets | 1.09 | (1.05-1.13) | < 0.001 | |
Anticoagulants | 1.48 | (1.42-1.54) | < 0.001 |
- Citation: Minhem MA, Nakshabandi A, Mirza R, Alsamman MA, Mattar MC. Gastrointestinal hemorrhage in the setting of gastrointestinal cancer: Anatomical prevalence, predictors, and interventions. World J Gastrointest Endosc 2021; 13(9): 391-406
- URL: https://www.wjgnet.com/1948-5190/full/v13/i9/391.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i9.391